Showing posts with label alcohol. Show all posts
Showing posts with label alcohol. Show all posts

Tuesday, December 09, 2008

ED Visits for Underage Drinkers

SAMHSA's Drug Abuse Warning Network (DAWN) reports this month on ED use by underage drinkers.
SAMHSA Releases New Data on Drug-related Hospital Emergency Department Visits (12/5/08)

The latest Drug Abuse Warning Network (DAWN) report - drawn from a sample of hospital emergency departments across the Nation - indicates that more than 1.7 million visits for treatment were associated with some form of substance misuse or abuse. The 2006 DAWN report, developed by the Substance Abuse and Mental Health Services Administration (SAMHSA), provides the latest estimates on how substance use affects this critical part of the Nation's healthcare system.

Click on the link for more information about the DAWN report
Key findings:
According to the Drug Abuse Warning
Network (DAWN):
  • During 2004, an estimated 142,701 alcohol-related emergency department (ED) visits were made by patients aged 12 to 20.
  • Nearly half (42%) of drug-related ED visits among patients aged 12 to 20 involved alcohol.
  • Patients aged 18 to 20 were approximately 3 times as likely as patients aged 12 to 17 to have an alcohol-related ED visit.
  • Visits involving alcohol with other drugs were almost 2 times as likely as visits involving only alcohol to result in admission to the hospital for inpatient care (19% vs. 10%).

Gender Drinking Gap

An article in the popular press discusses increases in female alcohol consumption.

Monday, November 24, 2008

Alcohol Taxes Saving Lives in Alaska

A recent study of mortality and tax data in Alaska reports increases in state taxes on alcohol purchases led to declines in death due to alcohol-related causes. See abstract below:
Effects of Alcohol Tax Increases on Alcohol-Related Disease Mortality in Alaska: Time-Series Analyses from 1976 to 2004

Alexander C. Wagenaar, Mildred M. Maldonado-Molina, Bradley H. Wagenaar

Objective. We evaluated the effects of tax increases on alcoholic beverages in 1983 and 2002 on alcohol-related disease mortality in Alaska.

Methods. We used a quasi-experimental design with quarterly measures of mortality from 1976 though 2004, and we included other states for comparison. Our statistical approach combined an auto regressive integrated moving average model with structural parameters in interrupted time-series models.

Results. We observed statistically significant reductions in the numbers and rates of deaths caused by alcohol-related disease beginning immediately after the 1983 and 2002 alcohol tax increases in Alaska. In terms of effect size, the reductions were –29% (Cohen’s d=–0.57) and –11% (Cohen’s d=–0.52) for the 2 tax increases. Statistical tests of temporary-effect models versus long-term effect models showed little dissipation of the effect over time.

Conclusions. Increases in alcohol excise tax rates were associated with immediate and sustained reductions in alcohol-related disease mortality in Alaska. Reductions in mortality occurred after 2 tax increases almost 20 years apart. Taxing alcoholic beverages is an effective public health strategy for reducing the burden of alcohol-related disease.

Monday, October 29, 2007

Research to Practice: Malt Liquor Sales

The University of Minnesota School of Public Health's alcohol epidemiology program is conducting a three year study, Local Efforts to Restrict Malt Liquor Sales (LERMLS), to investigate the effects of community restrctions on the sale of malt liquor.
Our three-year study, Local Efforts to Restrict Malt Liquor Sales (LERMLS) has three primary objectives:
  1. Determine whether the sale and consumption of malt liquor is perceived as a problem by city officials and document what has been done at the local level to restrict it....This aim will be accomplished by conducting a telephone survey of city officials and staff responsible for alcohol policy-making and enforcement in the 100 largest U.S. cities.

  2. Compare six cities’ efforts to adopt policies to restrict malt liquor sales and determine what factors were critical to their success or failure. This aim will be achieved by conducting a retrospective, comparative case study of three cities that successfully adopted policies that restrict malt liquor sales and three cities that were unsuccessful.

  3. Create a national database that provides summaries of key features of local policies that have been successfully adopted to restrict malt liquor sales on our Alcohol Epidemiology website (http://www.epi.umn.edu/alcohol), which is accessible to local policy makers, law enforcement officials, community groups, and researchers. The database will also include a summary of the literature on malt liquor consumption and policies to restrict its use, model ordinances that cities may wish to adapt to their communities, a summary of factors that may facilitate or impede adoption of these policies, and examples of measures that can be used to evaluate these policies.
Our study builds on findings from our Malt Liquor and Homicide (MLH) study, which investigated the role of alcohol and malt liquor availability and promotion in explaining disparities in homicide rates in inner-city neighborhoods in 10 U.S. cities including Santa Ana, Oakland, San Francisco, Kansas City (KS), Kansas City (MO), St. Paul, Minneapolis, Atlanta, Boston, and Baltimore. The MLH study was funded by the National Institute of Alcoholism and Alcohol Abuse.


Additional information on these studiecs can be found at the University of Minnesota School of Public Health's website.

Wednesday, October 10, 2007

Epilepsy Drug Fights Alcohol Addiction?

According to this report, a new study in the Journal of the American Medical Association (vol.298, no.14, p.1641) reports on the use of the epilepsy drug topiramate, an anti-convulsant (brand: Topamax), to curb alcohol consumption. The druge reduced both the volume of alcohol consumption per day and the frequency of heavy drinking.

Saturday, June 23, 2007

Gene Therapy for Alcoholism?

A new study suggests gene therapy can help curb alcoholism by manipulating a gene responsible for the metabolism of alcohol:
Aldehyde dehydrogenase is blocked by the drug disulfiram, also known as Antabuse, which is sometimes used to help alcoholics quit the habit. "But you have to take it every day, so there is a big problem with compliance," says Amalia Sapag at the University of Chile in Santiago.

To provide a longer-lasting effect, Sapag's team engineered adenoviruses to carry an "antisense" version of the aldehyde dehydrogenase gene. This produces RNA that binds to the original gene's messenger RNA, blocking enzyme production.

A single injection of viruses reduced the enzyme's activity in rats' livers by 80 per cent, Sapag revealed at the American Society of Gene Therapy meeting in Seattle earlier this month.